MIAUTON, A., AUDRAN, R., BESSON, J., MABY-EL HAJJAMI, H., KARLEN, M., WARPELIN-DECRAUSAZ, L., SENE, L., SCHAUFELBERGER, S., FAIVRE, V., FAOUZI, M., HARTLEY, M.A., SPERTINI, F. und GENTON, B., 2024. Safety and immunogenicity of a synthetic nanoparticle-based, T cell priming peptide vaccine against dengue in healthy adults in Switzerland: a double-blind, randomized, vehicle-controlled, phase 1 study. EBio Medicine, vol. 99, pp. 104922. 1 Januar 2024. DOI 10.1016/j.ebiom.2023.104922.
Elsevier - Harvard (with titles)Miauton, A., Audran, R., Besson, J., Maby-El Hajjami, H., Karlen, M., Warpelin-Decrausaz, L., Sene, L., Schaufelberger, S., Faivre, V., Faouzi, M., Hartley, M., Spertini, F., Genton, B., 2024. Safety and immunogenicity of a synthetic nanoparticle-based, T cell priming peptide vaccine against dengue in healthy adults in Switzerland: a double-blind, randomized, vehicle-controlled, phase 1 study. EBio Medicine, vol. 99, pp. 104922. https://doi.org/10.1016/j.ebiom.2023.104922
American Psychological Association 7th editionMiauton, A., Audran, R., Besson, J., Maby-El Hajjami, H., Karlen, M., Warpelin-Decrausaz, L., Sene, L., Schaufelberger, S., Faivre, V., Faouzi, M., Hartley, M., Spertini, F., & Genton, B. (2024). Safety and immunogenicity of a synthetic nanoparticle-based, T cell priming peptide vaccine against dengue in healthy adults in Switzerland: a double-blind, randomized, vehicle-controlled, phase 1 study. EBio Medicine, Vol. 99, Pp. 104922. https://doi.org/10.1016/j.ebiom.2023.104922
Springer - Basic (author-date)Miauton A, Audran R, Besson J, Maby-El Hajjami H, Karlen M, Warpelin-Decrausaz L, Sene L, Schaufelberger S, Faivre V, Faouzi M, Hartley M, Spertini F, Genton B (2024) Safety and immunogenicity of a synthetic nanoparticle-based, T cell priming peptide vaccine against dengue in healthy adults in Switzerland: a double-blind, randomized, vehicle-controlled, phase 1 study.. EBio Medicine, vol. 99, pp. 104922. https://doi.org/10.1016/j.ebiom.2023.104922
Juristische Zitierweise (Stüber) (Deutsch)Miauton, A./ Audran, R./ Besson, J./ Maby-El Hajjami, H./ Karlen, M./ Warpelin-Decrausaz, L./ Sene, L./ Schaufelberger, S./ Faivre, V./ Faouzi, M./ Hartley, M.A./ Spertini, F./ Genton, B., Safety and immunogenicity of a synthetic nanoparticle-based, T cell priming peptide vaccine against dengue in healthy adults in Switzerland: a double-blind, randomized, vehicle-controlled, phase 1 study., EBio Medicine, vol. 99, pp. 104922 2024.